UnitedHealthcare
Imbruvica (ibrutinib)
Drugs for Cancer : Drugs for Cancer
  • Orally administered anticancer medication.
  • Chronic Lymphocytic Leukemia:
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    Drug Policy Based On: Payer Specific
    Diagnosis Types: 1 of Chronic Lymphocytic Leukemia;Small Lymphocytic Lymphoma

    Diffuse Large B-Cell Lymphoma:
    Age Requirement: >= 19
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)

    Follicular Lymphoma (FL):
    Age Requirement: < 19
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)

    Graft Versus Host Disease (GVHD), Mantle Cell Lymphoma:
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)

    Marginal Zone Lymphoma:
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: = 12 month(s)

    Non Hodgkin Lymphoma (NHL):
    Age Requirement: <= 19
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: < 12 month(s)

    Waldenstrom Macroglobulinemia:
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Specialty Pharmacy Provider(s): Avella Specialty Pharmacy
    Reauthorization Required: Yes
    Duration of Reauthorization: Unspecified

  • Quantity Limit: limit maximum 1 EA PER 1 day(s)
  • Prior Authorization: Chronic Lymphocytic Leukemia, Graft Versus Host Disease (GVHD), Mantle Cell Lymphoma, Waldenstrom Macroglobulinemia:
    Documented Diagnosis: Yes
    Duration: 12 Month(s)
    Reauthorization Required: Yes

    Diffuse Large B-Cell Lymphoma:
    Documented Diagnosis: Yes
    Age Requirement: >= 19
    Duration: 12 Month(s)
    Reauthorization Required: Yes

    Follicular Lymphoma (FL):
    Documented Diagnosis: Yes
    Age Requirement: < 19
    Duration: 12 Month(s)
    Reauthorization Required: Yes

    Marginal Zone Lymphoma:
    Documented Diagnosis: Yes
    Duration: 12 Month(s)

    Non Hodgkin Lymphoma (NHL):
    Documented Diagnosis: Yes
    Age Requirement: <= 19
    Duration: 12 Month(s)
    Reauthorization Required: Yes